Christopher Todd

Christopher was awarded his Ph.D. in Genetics from Barts and the London School of Medicine and Dentistry, Queen Mary University of London, in September 2018. During his training at the Blizard Institute he performed research into the epigenetic regulation and enhancer activities of retrotransposons during early development.

Christopher joined the Babraham Institute in February 2019 as a Postdoctoral Researcher. Specialising in CRISPR technologies and bioinformatic analysis, Christopher currently studies epigenetic priming of enhancers within early human embryo development.